White ACE-031 powder for human growth peptides CAS 616204-22-9

Product Name:ACE-031
Alias:ACVR2B
CAS NO.:616204-22-9
Molecular Formula:C10H17N3O6S
Purity:85%
Specification:1mg/vial
Appearance:White Powder
Grade:Pharmaceutical Grade

ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting molecules that bind to and signal through a cell surface receptor called Activin Receptor Type IIB (ActRIIB). ACE-031 is a recombinant fusion protein that is produced by joining a portion of the human ActRIIB receptor to a portion of a human antibody. This creates a freely circulating, decoy version of ActRIIB which removes proteins, such as GDF-8 (myostatin) and other related molecules that limit the growth and strength of muscle.

Muscle growth is regulated by proteins in the TGF-ß protein superfamily that serve as "on" or "off" switches for muscle production. Several molecules including GDF-8 interact with the ActRIIB receptor and send an "off" signal to stop muscle production. In the absence of these "off" switch molecules that signal through the ActRIIB receptor, muscle mass increases dramatically. n nature, this effect has been observed in numerous species, particularly in animals that have been bred for increased musculature and strengt

ACE-031 Benefits

ACE-031 causes a huge increase in muscle mass and muscle strength that can supposedly compete over even the most efficient hardcore volume steroids, such as Oxymetholone.Taking ACE-031 results in the fast and almost immediate increase of muscle hardness.ACE-031 promotes fat burning.

ACE-031 Dosage

Even a small dose of ACE-031 of 1 mg can have a substantial effect. Sportsmen taking 1 mg of ACE-031 once a week over the period of 3-4 weeks report nearly an immediate increase in the muscle hardness and the rapid growth of muscle mass and strength to an extent exceeding even the most efficient hardcore volume anabolic-androgenic steroid, such as Oxymetholone!

Another dosing option is to start with the dose of 200 mcg of ACE-031 per day and to increase the dose every week by 100 mcg, whereas the treatment cycle should last again 3-4 weeks.

Once a cycle with ACE-031 is completed, a break in the duration of two weeks is recommended.

ACE-031 Side Effects

In clinical studies performed by Acceleron Pharma on a sample of adult males (volunteers), some study participants treated with ACE-031 experienced minor nose and gum bleeding and dilation of blood vessels in the skin. The majority of these side effects completely resolved once the treatment with ACE-031 was completed or discontinued.

Related Products